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Madhumeha has emerged as a global health hazard 
having tremendous socio-economic impact to the 
individual as well as society as a whole. In spite of 
tremendous advances in modern medical sciences, 
today Madhumeha (Diabetes Mellitus) is one of the 
most common non-communicable diseases.[1] 
Diabetes Mellitus is the most severe metabolic 
pandemic of the 21st century, affecting essential 
biochemical activities in  almost every cell in the body  
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and increasing the risk of cardiac problems. It is 
estimated that in the year 2000, 171 million people 
had diabetes and this is expected to double by the 
year 2030.[2] Though there are variety of 
Hypoglycaemic drugs available along with the use of 
insulin, there is an increase in demand of natural 
drugs producing hypoglycaemic effect.[3] Few 
researches have analysed the efficacy of various 
Dravyas mentioned in Ayurvedic classics for 
Madhumeha. Here an attempt was made to analyse 
the effect of “Arjuna Kaand Twak Choorna (Bark 
powder) of Terminalia arjuna Roxb.” which is used by 
many traditional practitioners as Hrudya Dravya. 
There is reference of use of Arjuna in Madhumeha in 
Bhavprakash Nighantu.[4]  
The analysis of Arjuna Kaand Twak Choorna indicated 
the presence of tannins, cardenolide, triterpenoid 
saponins (arjunic acid, arjunolic acid, arjungenin, 
glycosides), flavonoids, gallic acid, ellagic acid, 
phytosterols, calcium, magnesium, zinc, and copper. 
The present article here by is done to show the 
efficacy of Arjuna Kaand Twak Choorna in 
Madhumeha.[5] 
A B S T R A C T  
A clinical study was conducted on patients of Madhumeha resembling condition with Diabetes Mellitus, 
to evaluate the efficacy of Arjuna (Terminalia arjuna Roxb.) Kaand Twak Churna which is mentioned in 
traditional Bhavaprakash Nighantu as Madhumehahar. The present study was designed on newly 
diagnosed cases of Type II Diabetes Mellitus. The Aim and Objective of this study was to evaluate the 
efficacy of Arjuna (Terminalia arjuna Roxb.) Kaand Twak Churna on Madhumeha. This study was 
planned on 40 newly diagnosed cases of Diabetes Mellitus who were orally administered with Arjuna 
(Terminalia arjuna Roxb.) Kaand Twak Churna. Result obtained from study revealed that Kaand Twak 
Churna of Arjuna (Terminalia arjuna Roxb.) shows good effect in relieving the subjective criteria’s viz, 
Prabhutamutrata, Pippasa Vriddhi, Avila Mutrata, Swedaadhikya, Nidradhikya. It has also shown 
significant result in Objective criteria viz. FBS, PPBS, HBA1C. 
Key words: Arjuna, Kaand Twak Churna, Madhumeha, Diabetes Mellitus. 
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AIMS AND OBJECTIVES 
To evaluate the efficacy of Arjuna Kaand Twak 
Choorna (Terminalia arjuna Roxb.) in the 
management of Madhumeha. 
MATERIALS AND METHODS 
Source of Data 
Botanically identified Arjuna (Terminalia arjuna Roxb.) 
belonging to Combretaceae[6] family was procured 
from Smt. K. G. Mittal Ayurveda Mahavidyalaya, 
Garden, Kalina, Santacruz, and identified by 
Department of Dravyaguana Smt. K. G. Mittal 
Ayurveda Mahavidyalaya, Charni road, Mumbai, India. 
Authentified and Standardised by Alarsin 
Pharmaceuticals, Andheri, Mumbai, India. Finger 
printing analysis (HPTLC) was done at NFB, Khalsa 
College, Mumbai, India. 
Source of the Patients 
Patients were selected after subjecting them through 
clinical examination from OPD of Dravyaguna 
Department of Smt. K. G. Mittal Ayurveda 
Mahavidyalaya, Charni road, Mumbai, India. 
Preparation of Medicine 
A well identified bark of Arjuna was procured, the 
bark was cut in flat sawn, washed in running tap water 
then powdered and filtered in #60-85 (Puta Churna) 
sieve mesh. The sieve powder was stored in air tight 
container tillfurther clinical use. 
Shelf life of Churna Kalpana is- 2-3 month.[7] 
Place of Work 
Medicine was prepared at Rasashatra Department of 
Smt. K. G. Mittal Ayurveda Mahavidyalaya, Charni 
road, Mumbai, India. Clinical trial was conducted at 
Dravyaguna Department of Smt. K. G. Mittal Ayurveda 
Mahavidyalaya, Charni road, Mumbai, India. 
Method of Collection of Data 
Written and informed consent was taken of the 
enrolled patients based on the classical signs and 
symptoms of Madhumeha, the patients screening for 
inclusive criteria irrespective of sexes between the 
age group 18-60 years were selected from the OPD of 
Dravyaguna Department of Smt. K. G. Mittal Ayurveda 
Mahavidyalaya, Charni road, Mumbai, India. Totally 
40 patients were randomly selected for study 
according to inclusion and exclusion criteria. 
Drug Administration Details 
1)  Drug Arjuna Kanda Twak 
2)  Kalpana Churna 
3)  Dose 6 gm for 3 month 
4)  Sevan Kaal Pragbhakta 
5) Anupana Koshna Jala 
6)  Mode of Administration Oral 
Pathyapathya 
Without proper diet and lifestyle any medicine will 
not cure the disease.[8] Patient were advised to take 
standard diabetic diet according to Ayurvedic texts 
and modern medical science.[9] 
Clinical study based on inclusion and exclusion 
criteria 
Inclusion criteria 
1. Age- 18 to 60yrs 
2. Sex- Either 
3. Race- No Barrier 
4. Religion- No Barrier 
5. Economic Status- No Barrier 
6. If yes in any of the 2- 
a) Blood Sugar Level- Fasting >126 & 
=<200mg/dL or  Post Prandial >200mg/dL 
&<=300mg/dL or 
b) Glycated Hb > 7% &< 10% 
Exclusion criteria 
1. Patient below 18yrs and above 60yrs 
2. Malignant and accelerated hypertensive 
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3. Pregnant women or planning to be pregnant 
within 6month 
4. Lactating Mother 
5. Diabetes with known complications 
Follow-up 
1. Patient will be accessed clinically before and after 
15 days of the clinical study trial 
2. BSL will be accessed after 45 days before and 
after study. 
3. HbA1C will be accessed before and after study.                
Withdrawal criteria 
1. Patient not on regular follow-up. 
2. Aggravation of Symptoms 
3. Development of complications due to presenting 
illness or otherwise 
4. Any adverse drug effects. 
Assessment Criteria 
Subjective Parameters 
Gradation of symptoms[10] 
To access the change in the subjective symptoms of 
Madhumeha the clinical symptomology was graded 
into four (0-3). 
Study of changes in gradation of each symptom was 
done between, before and after treatment. Gradation 
done according to Clinical Research Protocol for 
Traditional Health Science. (Table 1) 
SN Criteria Detail Score 
1. Pippasa 
(Polydipsia)  
Daily normal quantity of water to 
quench thirst (<=2lit) With no 
Mukhasushkata 
0 
Requires additional water more 
than normal (2- 2.5lit) Still 
Mukhasushkata. 
1 
Requires additional water than 
normal (2.5 – 3lit) Still 
Mukhasushkata. 
2 
Requires additional water > 3lit. 





3 to 6 times per day, rarely at 
night. 
0 
6 to 9 times per day, 0 to 2 times 
at night. 
1 
9 to 12 times per day, 2 to 4 times 
at night. 
2 
More than 12 times per day, more 
than 4 times per night. 
3 
3. Avila Mutrata 
(turbidity) 
Crystal clear fluid.  0 
Faintly cloudy, smoky or hazy with 
turbidity barely visible. 
1 
Turbidity clearly visible but 
newsprint easily read through test 
tube. 
2 





Normal sleep, 6-8hours/24hours. 0 
Sleep upto 8hours/24hours with 
Angagaurava. 
1 
Sleep upto 8hours/24hours with 
Angagaurava and Jhrimba. 
2 
Sleep upto 10 hours/24hours with 
Tandra 
3 
Sleep upto>10hours/24hours with 




Sweating after heavy work and 
fast movement or in hot Weather.  
0 
Profuse sweating after moderate 
work and movement. 
1 
Sweating after little work and 
movement. 
2 
Profuse sweating after little work 
and movement. 
3 
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Sweating even at rest and/or in 
cold weather. 
4 
Statistical evaluation of treatment and result 
Clinical data obtained from patients was analysed 
statistically in terms of Mean score, Percentage of 
relief, Standard Deviation (S.D.), Standard Error (S.E.) 
by following tests.[11] 
1. Wilcoxon matched pairs signed ranks test:  
Comparison of symptoms grade score before and 
after treatment within Group is a qualitative data, 
so Wilcoxon matched pairs signed ranks test was 
applied for assessment of effect of treatment on 
symptom grade within Trial group and within 
Control group.   
2. Paired ‘t’ test: For assessment of effect of 
treatment on objective parameters before and 
after treatment within Group is a quantitative 
data, ‘Paired ‘t’ test’ was applied. 
Results were interpreted as;  
P<0.05 - Improvement, Significant 
Table 2: Subjective Criteria. 































































There was significant difference found in all 
symptoms. The P value is <0.05 which means the Trial 
drug in Madhumeha was effective with respect to 
above symptoms.  
Table 3: Objective Criteria. 
Variable Treatment Mean  S.D. Paired t 




BSL – F BT 141.45 10.028 19.36 < 
0.0001 




BSL – PP BT 229.3 19.252 11.473 < 
0.0001 
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HbA1C BT 7.475 0.274 15.452 < 
0.0001 




Statistical Analysis of the effect of therapy on 
Objective parameters of 40 patients of Madhumeha 
by paired ‘t’ test: 
▪ BSL - Fasting Mean of difference was 26.3± 8.584, 
paired t was19.36; P <0.05 significant, which 
suggests that difference of mean exhibited by 
Trial Drug was significant.  
▪ BSL - Post Prandial Mean of difference was 
40.175±6.096, paired t was11.473; P <0.05 
significant, which suggests that difference of 
mean exhibited by Trial Drug was significant.  
▪ HbA1C Mean of difference was 1.065± 0.0435, 
paired t was15.452; P <0.05 significant, which 
suggests that difference of mean exhibited by 
Trial Drug was significant.  
Comparison of Numerical Data before and After 
Within the groups was statistically evaluated by 
“paired-t test”. The value of ‘t’ is 19.36, 11.47, and 
15.45, while P-value is less than 0.05, which was 
statistically significant suggestive of significant 
difference with respect to effect of therapy on 
Objective Criteria. Hence null hypothesis is rejected. 
Total effects of treatment  
In the present study, 40 patients of Madhumeha were 
registered and treated with Trial Drug i.e. Arjuna 
Kaand Twak Churna. 
Table 4: Showing effect on symptoms score of 40 













74 28 46 62.16% 




36 11 25 69.44% 
4. Nidradhikya 59 22 37 62.71% 
5. Swedadhikya 54 21 33 61.11% 
Effect of therapy on symptom score 
It was observed that overall percentage of relief was 
more by Trial drug (60.38%). The symptoms such as 
Pipasa-vriddhi, Prabhuta-Mutrata, Avila-Mutrata, 
Nidradhikya, and Swedadhikya were studied in this 
trial as described here before in table. Percentage of 
relief for all the symptoms is more by Trial Drug. 
Table 5: Showing effect on Objective Parameters of 











1. BSL- F 141.45 115.175 26.275 18.691% 
2. BSL- PP 229.3 189.125 40.175 17.52% 
3. HbA1C 7.475 6.41 1.065 14.745% 
Effect of therapy on Objective parameters 
It was observed that overall percentage of relief was 
more by Trial drug i.e. 18.69%(BSL-F), 17.52%(BSL-PP), 
and 14.74% (HbA1C). Percentage of relief for all the 
Objectivess is more by Trial Drug. 
DISCUSSION 
Selection of Problem 
Diet and lifestyle are major factors to influence 
susceptibility to many diseases. Man has adapted 
himself to the fast-paced life by modifying dietary and 
lifestyle preferences to suit this modern era. This has 
resulted in a state of discrepancy between the 
external environment and internal mechanism causing 
many diseases which are popularly referred as ‘life-
style-diseases’ and “Diabetes” is one of them. 
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Plan of study 
After the permission from Ethical Committee 
approved by University, we randomly selected 40 
patients of Madhumeha having their written consent 
and were administered Arjuna Kaand Twak Churna 
6gms twice a day Pragbhakta (before meal) because 
any Disease that has affects Vrukka, the Drug is given 
in Apaan Kaal[12] for 14 weeks. All the patients were 
strictly examined according to the criteria of diagnosis 
and included in the study. Blood Sugar level (Fasting 
and Post Prandial) was done before treatment and at 
an interval of 4th, 8th weeks as well as HbA1C was 
done before and after treatment to observe the 
effects. For the purpose of symptomatic 
improvement, a follow-up of two weeks was kept. All 
concerned symptoms and investigations, detailed 
history and Rugna-Pariksha were recorded in the CRF. 
Discussion on mode of action of Arjuna 
As Ayurveda Samprapti and Samprapti Bhanga both 
depends on Panchbhuta Sanghatana. i.e. Dosha, 
Dushya, Strotasa, Agni, Ama. So, hereby put forth the 
probable mode of action.  
Samprapti Bhanga of Madhumeha by Arjuna[13-15] 
Rasa - Kashaya - Kleda, Meda Shoshak; Lekhana, 
Shoshana 
Virya - Sheeta   
Vipaka - Katu, Ruksha, Laghu (Reduces Meda) 
Guna - Laghu- Kaphaghna, Lekhana, Ruksha- Meda 
Shoshana 
Karma - Medohara- Kleda, Medahara 
Discussion on total effect of therapy 
Effect of therapy on symptom score 
It was observed that overall percentage of relief was 
more by Trial drug (61.67%). The symptoms such as 
Pipasa-vriddhi, Prabhuta-Mutrata, Avila-Mutrata, 
Nidradhikya, and Swedadhikya were studied in this 
trial as described here before in table. Percentage of 
relief for all the symptoms is more by Trial Drug. 
Effect of therapy on Objective parameters 
It was observed that overall percentage of relief was 
more by Trial drug i.e. 18.69% (BSL-F), 17.52%(BSL-
PP), and 14.74% (HbA1C). Percentage of relief for all 
the Objectives is more by Trial Drug. 
Adverse drug effect 
Amongst 40 patients, it was observed that 3 patients 
had symptom of Sore throat. Age limit of these 3 
patients was 45-55years and Prakriti Vata-Kaphaja. 
CONCLUSION 
Madhumeha known as silent killer needs to be 
treated asearly as possible to stop onset of further 
Diabetic complication. Arjuna (Terminalia arjuna 
Roxb.) a very easily available drug can be used to heal 
Madhumeha. Arjuna has improved quality of life to all 
the patients who have undergone clinical trial. Ekal 
Dravya (Single drug) treatment like Arjuna Kaand 
Twak Churna can prove boon to the world wide. 
Majority of Population suffering from Diabetes 
mellitus comprising of sedentary lifestyle. The change 
in their lifestyle i.e. Pathyakara Aahara-Vihara 
followed by regular practice of Yogasanas will help in 
treatment of Madhumeha. This pilot study proves that 
Arjuna Kaand Twak Choorna is an efficient as well as 
an ideal drug for its Madhumehahara property. 
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